On March 10, a small but mighty group of Endocrine Society members came to Washington D.C., to meet with their congressional delegations. Despite a number of other priorities requiring the attention of Congress, the federal appropriations process for FY 2021 must move forward and this is the time to influence decisions about funding. We used...
A novel way to reach even more patients, clinicians, and researchers is to take your endocrinology skill into the business world. Here we highlight an ENDO 2020 session that will show attendees how industry could be a viable route for researchers and physicians alike. Last year, at ENDO 2019 in New Orleans, three entrepreneurs at...
The Endocrine Society is pleased a South Dakota bill that would have barred healthcare providers from treating transgender teenagers using evidence-based clinical practice guidelines is not moving forward this session. Several states are considering legislation that would carry penalties of jail time and fines for healthcare providers who treat transgender teenagers using evidence-based practices. These...
U.S. Representative Charlie Crist (D-St. Petersburg) today announced the introduction of the Affordable Insulin for All Act (H.R. 5749) — legislation that would slash the price of life-sustaining insulin for every American living with diabetes. The bill would create the American Insulin Program, expanding the deep discount drug manufacturers currently give to Medicaid patients, to every American who...
The Endocrine Society praised the European Parliament resolution in response to the European Union’s “Green Deal”— a plan to invest more than €1 trillion in environmental initiatives, including important provisions to protect people from exposure to endocrine-disrupting chemicals (EDCs). Launched on December 11, the Green Deal contains a commitment to produce a chemicals strategy for...
Endocrine Society Advocates European Union Lawmakers About EDCs
On December 3-4, following the 2019 European Union (EU) elections and with the installment of the new European Commission, the Endocrine Society brought members from seven EU Member States to Brussels to meet with policy makers and urge them to take action on endocrine-disrupting chemicals (EDCs). A full day of meetings began with a briefing...
Before Congress adjourned for the holidays, the House of Representatives was able to advance legislation that reflected some Endocrine Society priorities related to EDCs. On December 3, Rep. Frank Pallone (D-NJ) introduced the Cosmetic Safety Enhancement Act (HR 5279), which would give the U.S. Food and Drug Administration (FDA) additional authority to regulate harmful chemicals...
After months of bargaining and numerous stalemates, the House of Representatives and Senate reached agreement on Fiscal Year 2020 appropriations just before funding expired on December 20. The deal also provided a “Christmas Tree” legislative vehicle for various policy measures. The spending deal was divided into two packages of individual bills covering funding for every...
Endocrinology Advocacy
Not all topics of relevance to endocrinologists are about specific conditions and diseases. Sometimes, doctors need information about changes in the medical field or the field of endocrinology. Changes to medical insurance legislation, drug trial regulations and even patient privacy legislation all impact a practitioner’s way of doing business and practicing medicine. Yet keeping track of these details is not always easy. That’s why Endocrine News has organized articles and news pieces on these topics into this advocacy page. Here, practitioners can find the information gathered by the Endocrine Society, a leading endocrinology advocacy organization, conveniently in one location.
Important Advocacy Information From the Endocrine Society
As an endocrinology advocacy organization, the Endocrine Society is constantly working to advocate for endocrinologists and their patients, both in the government and in various research centers across the country. Here on Endocrine News, you can stay informed about these efforts and their results, so you are well aware of what changes may be coming that affect your practice. This is an invaluable resource for doctors who wish to spend their time focusing on their patients, rather than advocating for their practices, but also wish to stay informed about what is happening in the field.
Both Clinical and Research Advocacy Information
On the Advocacy page, Endocrine News provides advocacy information relevant to both those in the research field and those practicing on a clinical level. Stay up to date with the activities of the Endocrine Society, learn more about the legislation that affects your work, and see highlights of leading researchers who are pioneering not only advances in the practice but also advocacy for endocrinology as a field. By utilizing the resources on the Advocacy page, you will be better equipped to meet the needs of your patients while staying abreast on the changes affecting the industry.
